(Q52076050)

21 April 2018

title

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal. (English)

1 reference

21 April 2018

0 references

Kleber HD

1

1 reference

21 April 2018

Topazian M

2

1 reference

21 April 2018

Gaspari J

3

1 reference

21 April 2018

Riordan CE

4

1 reference

21 April 2018

Kosten T

5

1 reference

21 April 2018

publication date

1 January 1987

1 reference

21 April 2018

American Journal of Drug and Alcohol Abuse

published in

1 reference

21 April 2018

volume

13

1 reference

21 April 2018

issue

1-2

1 reference

21 April 2018

page(s)

1-17

1 reference

21 April 2018

Clonidine blocks acute opiate-withdrawal symptoms

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Outpatient vs Hospital Methadone Detoxification: An Experimental Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Short-term, ambulatory detoxification of opiate addicts using methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Chronic morphine administration increases the apparent number of α2-adrenergic receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Clonidine overdose: report of six cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

The safety and value of naloxone as a therapeutic aid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Initial methadone dose in treating opiate addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Drug therapy: clonidine, a new antihypertensive drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Multiple Mechanisms of withdrawal from Opioid Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Noradrenergic neurons: morphine inhibition of spontaneous activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Iontophoretic application of opiates to the locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Chronic naloxone results in prolonged increases in opiate binding sites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Some thoughts on the significance of enkephalin, the endogenous ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Opioid peptides (endorphins) in pituitary and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Nontolerance to the opioid antagonism of naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

Strategies to Improve Compliance with Narcotic Antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00952998709001497

10.3109/00952998709001497

21 January 2018

Identifiers

DOI

1 reference

21 April 2018

1 reference

21 April 2018